欢迎光临河源广谱生物技术有限公司!
(+)-Cloprostenol
G-C-006649
54276-21-0
C22H29ClO6
424.93
中文名称 (+)-Cloprostenol
中文别名 ( )-氯前列烯醇;(5Z)-7-[(1R,2R,3R,5S)-2-[(1E,3R)-4-(3-氯苯氧基)-3-羟基-1-丁烯-1-基]-3,5-二羟基环戊基]-5-庚烯酸;(+)-氯前列醇;(+)-氯前列烯醇;氯前列烯醇
英文名称 (+)-Cloprostenol
英文别名 ( )-Cloprostenol;(5Z)-7-[(1R,2R,3R,5S)-2-[(1E,3R)-4-(3-Chlorophenoxy)-3-hydroxy-1-buten-1-yl]-3,5-dihydroxycyclopentyl]-5-heptenoic acid;(+)-Cloprostenol;(+/-)-9-methyl-3,9-diazabicyclo[4.2.1]nonane;(Z)-7-(2-((E)-4-(3-chlorophenoxy)-3-hydroxybut-1-enyl)-3,5-dihydroxycyclopentyl)hept-5-enoic acid;3,9-Diazabicyclo[4.2.1]nonane,9-methyl-;9-methyl-3,9-diazabicyclo-[4.2.1]nonane;9-methyl-3,9-diazabicyclo-[4.2.1]-nonane;9-METHYL-3,9-DIAZABICYCLO[4.2.1]NONANE;ACMC-20m5i7;AGN-PC-00BJCD;Cloprostenol;CTK4;SureCN929913;EINECS 255-028-8;EINECS 255-028-8;HMS3402O21;HMS3402O21;5-Heptenoic acid, 7-((1R,2R,3R,5S)-2-((1E,3R)-4-(3-chlorophenoxy)-3-hydroxy-1-butenyl)-3,5-dihydroxycyclopentyl)-, (5Z)-rel-;5-Heptenoic acid, 7-((1R,2R,3R,5S)-2-((1E,3R)-4-(3-chlorophenoxy)-3-hydroxy-1-butenyl)-3,5-dihydroxycyclopentyl)-, (5Z)-rel-;(+-)-(Z)-7-((1R*,2R*,3R*,5S*)-2-((E)-(3R*)-4-(3-Chlorophenoxy-3-hydroxy-1-butenyl)-3,5-dihydroxycyclopentyl)-5-heptensaeure;(+-)-(Z)-7-((1R*,2R*,3R*,5S*)-2-((E)-(3R*)-4-(3-Chlorophenoxy-3-hydroxy-1-butenyl)-3,5-dihydroxycyclopentyl)-5-heptensaeure;GTPL1894;GTPL1894;NCGC00161343-03;NCGC00161343-03;(Z)-7-((1R,2R,3R,5S)-2-((R,E)-4-(3-Chlorophenoxy)-3-hydroxybut-1-en-1-yl)-3,5-dihydroxycyclopentyl)hept-5-enoic acid;(Z)-7-((1R,2R,3R,5S)-2-((R,E)-4-(3-Chlorophenoxy)-3-hydroxybut-1-en-1-yl)-3,5-dihydroxycyclopentyl)hept-5-enoic acid;16-(M-CHLOROPHENOXY)-17,18,19,20-TETRANORPROSTAGLANDIN F2.ALPHA.;16-(M-CHLOROPHENOXY)-17,18,19,20-TETRANORPROSTAGLANDIN F2.ALPHA.;AC-6104;AC-6104;(+-)-Cloprostenol;(+-)-Cloprostenol;DTXSID7048372;DTXSID7048372;5-Heptenoic acid, 7-(2-(4-(3-chlorophenoxy)-3-hydroxy-1-butenyl)-3,5-dihydroxycyclopentyl)-, (1-alpha-(Z),2-beta-(1E,3R*),3-alpha,5-alpha)- (+-)-;5-Heptenoic acid, 7-(2-(4-(3-chlorophenoxy)-3-hydroxy-1-butenyl)-3,5-dihydroxycyclopentyl)-, (1-alpha-(Z),2-beta-(1E,3R*),3-alpha,5-alpha)- (+-)-;HMS1989O21;HMS1989O21;SR-01000946503-1;SR-01000946503-1;cloprostenol;cloprostenol;5-Heptenoic acid, 7-((1R,2R,3R,5S)-2-((1E,3R)-4-(3-chlorophenoxy)-3-hydroxy-1-butenyl)-3,5-dihydroxycyclopentyl)-, (5Z)-;CLOPROSTENOL, (+/-)-;5-Heptenoic acid, 7-((1R,2R,3R,5S)-2-((1E,3R)-4-(3-chlorophenoxy)-3-hydroxy-1-butenyl)-3,5-dihydroxycyclopentyl)-, (5Z)-;Estrophan;CLOPROSTENOL, (+/-)-;16-(m-Chlorophenoxy)-17,18,19,20-tetranorprostaglandin F2alpha;Estrophan;Q27076117;16-(m-Chlorophenoxy)-17,18,19,20-tetranorprostaglandin F2alpha;Cloprostenolum (INN-Latin);Q27076117;CS-7779;Cloprostenolum (INN-Latin);(Z)-7-((1R,2R,3R,5S)-2-((R,E)-4-(3-Chlorophenoxy)-3-hydroxybut-1-en-1-yl)-3,5-dihydroxycyclopentyl)hept-5-enoicacid;CS-7779;52EJR3Y9IN;(Z)-7-((1R,2R,3R,5S)-2-((R,E)-4-(3-Chlorophenoxy)-3-hydroxybut-1-en-1-yl)-3,5-dihydroxycyclopentyl)hept-5-enoicacid;(Z)-7-[(1R,2R,3R,5S)-2-[(E,3R)-4-(3-chlorophenoxy)-3-hydroxybut-1-enyl]-3,5-dihydroxycyclopentyl]hept-5-enoic acid;52EJR3Y9IN;REL-(5Z)-7-((1R,2R,3R,5S)-2-((1E,3R)-4-(3-CHLOROPHENOXY...
CAS No. 54276-21-0
分子式 C22H29ClO6
分子量 424.93
密度 1.321
沸点 627.99 °C at 760 mmHg
象形图
提示语
风险术语
警告声明
信号词
危险声明
Packing Group